↓ Skip to main content

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Overview of attention for article published in Breast Cancer Research, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
142 Dimensions

Readers on

mendeley
104 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
Published in
Breast Cancer Research, March 2011
DOI 10.1186/bcr2841
Pubmed ID
Authors

Ola Blixt, Deanna Bueti, Brian Burford, Diane Allen, Sylvain Julien, Michael Hollingsworth, Alex Gammerman, Ian Fentiman, Joyce Taylor-Papadimitriou, Joy M Burchell

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Malaysia 1 <1%
Denmark 1 <1%
Germany 1 <1%
Unknown 99 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 27%
Student > Ph. D. Student 27 26%
Student > Master 11 11%
Student > Bachelor 9 9%
Professor 5 5%
Other 15 14%
Unknown 9 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 25 24%
Biochemistry, Genetics and Molecular Biology 18 17%
Medicine and Dentistry 17 16%
Chemistry 14 13%
Immunology and Microbiology 6 6%
Other 7 7%
Unknown 17 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 November 2020.
All research outputs
#3,912,384
of 19,315,352 outputs
Outputs from Breast Cancer Research
#527
of 1,786 outputs
Outputs of similar age
#65,249
of 274,848 outputs
Outputs of similar age from Breast Cancer Research
#7
of 16 outputs
Altmetric has tracked 19,315,352 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,786 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,848 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.